Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'vWF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 276 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schneppenheim, R; Budde, U; Ruggeri, ZM
      A molecular approach to the classification of von Willebrand disease

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    2. Favaloro, EJ
      Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    3. Furlan, M; Lammle, B
      Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    4. Scheja, A; Akesson, A; Geborek, P; Wildt, M; Wollheim, CB; Wollheim, FA; Vischer, UM
      Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)

      ARTHRITIS RESEARCH
    5. Cohen, AJ; Kessler, CM; Ewenstein, BM
      Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America

      HAEMOPHILIA
    6. Huchon, D; Douzery, EJP
      From the old world to the new world: A molecular chronicle of the phylogeny and biogeography of Hystricognath rodents

      MOLECULAR PHYLOGENETICS AND EVOLUTION
    7. O'Donnell, J; Laffan, MA
      The relationship between ABO histo-blood group, factor VIII and von Willebrand factor

      TRANSFUSION MEDICINE
    8. Blann, AD; Gurney, D; Wadley, M; Bareford, D; Stonelake, P; Lip, GYH
      Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and vonWillebrand factor

      BLOOD COAGULATION & FIBRINOLYSIS
    9. Grunkemeier, JM; Tsai, WB; Horbett, TA
      Co-adsorbed fibrinogen and von Willebrand factor augment platelet procoagulant activity and spreading

      JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
    10. Lip, GYH; Edmunds, E; Hee, FLLS; Blann, AD; Beevers, DG
      A cross-sectional, diurnal, and follow-up study of platelet activation andendothelial dysfunction in malignant phase hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    11. Michaux, J; Reyes, A; Catzeflis, F
      Evolutionary history of the most speciose mammals: Molecular phylogeny of muroid rodents

      MOLECULAR BIOLOGY AND EVOLUTION
    12. Fukuchi, M; Watanabe, J; Kumagai, K; Katori, Y; Baba, S; Fukuda, K; Yagi, T; Iguchi, A; Yokoyama, H; Miura, M; Kagaya, Y; Sato, S; Tabayashi, K; Shirato, K
      Increased von Willebrand factor in the endocardium as a local predisposingfactor for thrombogenesis in overloaded human atrial appendage

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    13. Lee, YJ; Shin, KC; Kang, SW; Lee, EB; Kim, HA; Song, YW
      Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    14. Favaloro, EJ; Aboud, M; Arthur, C
      Possibility of potential VWD misdiagnosis or misclassification using LIA technology and due to presence of rheumatoid factor

      AMERICAN JOURNAL OF HEMATOLOGY
    15. Zareba, W; Pancio, G; Moss, AJ; Kalaria, VG; Marder, VJ; Weiss, HJ; Watelet, LFM; Sparks, CE
      Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients

      THROMBOSIS AND HAEMOSTASIS
    16. Ribba, AS; Loisel, I; Lavergne, JM; Juhan-Vague, I; Obert, B; Cherel, G; Meyer, D; Girma, JP
      Ser968Thr mutation within the A3 domain of von Willebrand Factor (VWF) in two related patients leads to a defective binding of VWF to collagen

      THROMBOSIS AND HAEMOSTASIS
    17. Jilma-Stohlawetz, P; Hergovich, N; Homoncik, M; Dzirlo, L; Horvath, M; Janisiw, M; Panzer, S; Jilma, B
      Impaired platelet function among platelet donors

      THROMBOSIS AND HAEMOSTASIS
    18. Kasirer-Friede, A; Legrand, C; Frojmovic, MM
      Complementary roles for fibrin(ogen), thrombospondin and vWF in mediating shear-dependent aggregation of platelets stimulated at threshold thrombin concentrations

      THROMBOSIS AND HAEMOSTASIS
    19. Costa, M; Grant, PJ; Rice, GI; Futers, TS; Medcalf, RL
      Human endothelial cell-derived nuclear proteins that recognise polymorphicDNA elements in the von Willebrand factor gene promoter include YY1

      THROMBOSIS AND HAEMOSTASIS
    20. van Mourik, JA; de Wit, TR
      Von Willebrand factor propeptide in vascular disorders

      THROMBOSIS AND HAEMOSTASIS
    21. Goodeve, AC; Eikenboom, JCJ; Ginsburg, D; Hilbert, L; Mazurier, C; Peake, IR; Sadler, JE; Rodeghiero, F
      A standard nomenclature for von Willebrand factor gene mutations and polymorphisms

      THROMBOSIS AND HAEMOSTASIS
    22. Prajapati, K; Hes, P
      Reduction of hand-arm transmitted vibration on pneumatic jackleg rock drills

      CIM BULLETIN
    23. Li-Saw-Hee, FL; Beevers, DG; Lip, GYH
      Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    24. Broberg, M; Nygren, H
      Von Willebrand factor, a key protein in the exposure of CD62P on platelets

      BIOMATERIALS
    25. Xu, YY; Narayana, SVL; Volanakis, JE
      Structural biology of the alternative pathway convertase

      IMMUNOLOGICAL REVIEWS
    26. Sutor, AH; Thomas, KB; Prufer, FHA; Grohmann, A; Brandis, M; Zimmerhackl, LB
      Function of von Willebrand factor in children with diarrhea-associated hemolytic-uremic syndrome (D+ HUS)

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    27. He, S; Cao, HL; Magnusson, CGM; Eriksson-Berg, M; Mehrkash, M; Schenck-Gustafsson, K; Blomback, M
      Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein

      THROMBOSIS RESEARCH
    28. Christodoulides, N; Feng, SJ; Resendiz, JC; Berndt, MC; Kroll, MH
      Glycoprotein Ib/IX/V binding to the membrane skeleton maintains shear-induced platelet aggregation

      THROMBOSIS RESEARCH
    29. Onitsuka, I; Jung, SM; Ikeda, H; Imaizumi, T; Moroi, M
      Real-time analysis of the interaction of platelets with immobilized thrombospondin under flow conditions

      THROMBOSIS RESEARCH
    30. Kageyama, S; Yamamoto, H; Nakazawa, H; Yoshimoto, R
      Anti-human vWF monoclonal antibody, AJvW-2 fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs

      THROMBOSIS RESEARCH
    31. van Dongen, AM; van Leeuwen, M; Slappendel, RJ
      Canine von Willebrand's disease type 2 in German wirehair pointers in the Netherlands

      VETERINARY RECORD
    32. Kanthaswamy, S; Bininda-Emonds, ORP; Warden, C; Viray, JL; Smith, DG
      Use of SSR fragment length homozygotes for orangutan systematics

      PRIMATES
    33. Soejima, K; Mimura, N; Hirashima, M; Maeda, H; Hamamoto, T; Nakagaki, T; Nozaki, C
      A novel human metalloprotease synthesized in the liver and secreted into the blood: Possibly, the von Willebrand factor-cleaving protease?

      JOURNAL OF BIOCHEMISTRY
    34. Gasparovic, V; Mejic, S; Pisl, Z; Radonic, R; Radman, I
      Thrombotic thrombocytopenic purpura - possibilities of treatment and results

      HAEMATOLOGIA
    35. Veyradier, A; Balian, A; Wolf, M; Giraud, V; Montembault, S; Obert, B; Dagher, I; Chaput, JC; Meyer, D; Naveau, S
      Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract

      GASTROENTEROLOGY
    36. Barbot, J; Costa, E; Guerra, M; Barreirinho, MS; Isvarlal, P; Robles, R; Gerritsen, HE; Lammle, B; Furlan, M
      Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease

      BRITISH JOURNAL OF HAEMATOLOGY
    37. Loof, AH; van Vliet, HHDM; Kappers-Klunne, MC
      Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura

      BRITISH JOURNAL OF HAEMATOLOGY
    38. Casonato, A; Pontara, E; Bertomoro, A; Sartorello, F; Cattini, MG; Girolami, A
      Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?

      BRITISH JOURNAL OF HAEMATOLOGY
    39. Veyradier, A; Obert, B; Houllier, A; Meyer, D; Girma, JP
      Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

      BLOOD
    40. Turner, NA; Moake, JL; McIntire, LV
      Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is requiredto inhibit platelet aggregation in whole blood under flow

      BLOOD
    41. Ribba, AS; Hilbert, L; Lavergne, JM; Fressinaud, E; Boyer-Neumann, C; Ternisien, C; Juhan-Vague, I; Goudemand, J; Girma, JP; Mazurier, C; Meyer, D
      The arginine-552-cysteine (R1315C) mutation within the Al loop of von Willebrand factor induces an abnormal folding with a loss of function resultingin type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor

      BLOOD
    42. Studt, JD; Budde, U; Schneppenheim, R; Eisert, R; Prondzinski, MV; Ganser, A; Barthels, M
      Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry

      AJCP. American journal of clinical pathology
    43. Bounameaux, H; Kruithof, EKO
      On the association of elevated tPA/PAI-1 complex and von Willebrand factorwith recurrent myocardial infarction

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    44. Souto, JC; Almasy, L; Muniz-Diaz, E; Soria, JP; Borrell, M; Bayen, L; Mateo, J; Madoz, P; Stone, W; Blangero, J; Fontcuberta, J
      Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    45. Raife, TJ; Montgomery, RR
      von Willebrand factor and thrombotic thrombocytopenic purpura

      CURRENT OPINION IN HEMATOLOGY
    46. Huchon, D; Catzeflis, FM; Douzery, EJP
      Variance of molecular datings, evolution of rodents and the phylogenetic affinities between Ctenodactylidae and Hystricognathi

      PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    47. Yano, T; Tanikawa, S; Fujie, T; Masutani, M; Horie, T
      Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    48. Satoh, K; Asazuma, N; Yatomi, Y; Fujimura, Y; Miura, S; Titani, K; Ozaki, Y
      Activation of protein-tyrosine kinase pathways in human platelets stimulated with the A1 domain of von Willebrand factor

      PLATELETS
    49. Furlan, M; Lammle, B
      Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura - new insights into underlying biochemical mechanisms

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    50. Wang, YC; Li, ZY; Gu, JM; Ruan, CG
      von Willebrand disease in China

      CHINESE MEDICAL JOURNAL
    51. Nitu-Whalley, IC; Riddell, A; Lee, CA; Pasi, KJ; Owens, D; Enayat, MS; Perkins, SJ; Jenkins, PV
      Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients. a reappraisal using phenotypes, genotypes and molecular modelling

      THROMBOSIS AND HAEMOSTASIS
    52. Favaloro, EJ; Henniker, A; Facey, D; Hertzberg, M
      Discrimination of von Willebrands disease (VWD) subtypes: Direct comparison of von Willebrand factor : collagen binding assay (VWF : CBA) with monoclonal antibody (MAB) based VWF-capture systems

      THROMBOSIS AND HAEMOSTASIS
    53. Vanhoorelbeke, K; van der Plas, RM; Vandecasteele, G; Vauterin, S; Huizinga, EG; Sixma, JJ; Deckmyn, H
      Sequence alignment between VWF and peptides inhibiting the vWF-collagen interaction does not result in the identification of a collagen-binding site in VWF

      THROMBOSIS AND HAEMOSTASIS
    54. Enayat, MS; Guilliatt, AM; Surdhar, GK; Theopilus, BDM; Hill, FGH
      A new candidate missense mutation (Leu 1657 IIe) in an apparently asymptomatic type 2A (phenotype IIA) von Willebrand disease family

      THROMBOSIS AND HAEMOSTASIS
    55. Veyradier, A; Jenkins, CSP; Fressinaud, E; Meyer, D
      Acquired von Willebrand syndrome: from pathophysiology to management

      THROMBOSIS AND HAEMOSTASIS
    56. Hilbert, L; Jenkins, PV; Gaucher, C; Meriane, E; Collins, PW; Pasi, KJ; Mazurier, C
      Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor

      THROMBOSIS AND HAEMOSTASIS
    57. Tout, H; Obert, B; Houllier, A; Fressinaud, E; Rothschild, C; Meyer, D; Girma, JP
      Mapping and functional studies of two alloantibodies developed in patientswith type 3 von Willebrand disease

      THROMBOSIS AND HAEMOSTASIS
    58. Vanhoorelbeke, K; Cauwenberghs, N; Vauterin, S; Schlammadinger, A; Mazurier, C; Deckmyn, H
      A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor

      THROMBOSIS AND HAEMOSTASIS
    59. Favaloro, EJ
      Collagen binding assay for von Willebrand factor (VWF : CBA): Detection ofvon Willebrands Disease (VWD), and discrimination of VWD subtypes, dependson collagen source

      THROMBOSIS AND HAEMOSTASIS
    60. Galbusera, M; Remuzzi, A; Benigni, A; Rossi, C; Remuzzi, G
      A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow

      AMERICAN JOURNAL OF KIDNEY DISEASES
    61. Harada, K; Lu, SQ; Chisholm, DM; Syrjanen, S; Schor, AM
      Angiogenesis and vasodilation in skin warts. Association with HPV infection

      ANTICANCER RESEARCH
    62. Grunkemeier, JM; Tsai, WB; McFarland, CD; Horbett, TA
      The effect of adsorbed fibrinogen, fibronectin, von Willebrand factor and vitronectin on the procoagulant state of adherent platelets

      BIOMATERIALS
    63. Spadafora-Ferreira, M; Lopes, AAB; Coelho, V; Guilherme, L; Kalil, J
      Two novel anti-von Willebrand Factor monoclonal antibodies

      THROMBOSIS RESEARCH
    64. Mazzini, J; Hackel, C; Annichino-Bizzacchi, JM
      Allelic frequencies of three VNTRs in intron 40 of the human von Willebrand factor gene in types 1, 2, and 3 von Willebrand disease patients and controls of a Brazilian population

      THROMBOSIS RESEARCH
    65. Onohara, T; Komori, K; Yamamura, S; Fujinaga, Y; Sugimachi, K
      Modulation of platelet aggregation after percutaneous transluminal angioplasty of the iliac artery for atherosclerosis obliterans

      SURGERY
    66. Hinshelwood, J; Perkins, SJ
      Metal-dependent conformational changes in a recombinant vWF-A domain from human factor B: A solution study by circular dichroism, Fourier transform infrared and H-1 NMR spectroscopy

      JOURNAL OF MOLECULAR BIOLOGY
    67. Allford, SL; Machin, SJ
      Current understanding of the pathophysiology of thrombotic thrombocytopenic purpura

      JOURNAL OF CLINICAL PATHOLOGY
    68. Grunkemeier, JM; Tsai, WB; Alexander, MR; Castner, DG; Horbett, TA
      Platelet adhesion and procoagulant activity induced by contact with radiofrequency glow discharge polymers: Roles of adsorbed fibrinogen and vWF

      JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
    69. Miura, S; Li, CQ; Cao, ZF; Wang, HF; Wardell, MR; Sadler, JE
      Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ib alpha-(1-289) - Slow intrinsic binding kinetics mediate rapid platelet adhesion

      JOURNAL OF BIOLOGICAL CHEMISTRY
    70. Ribau, JCO; Samis, JA; Senis, YA; Maurice, DH; Giles, AR; DeReske, M; Absher, PM; Hatton, MWC; Richardson, M
      Aortic endothelial cell von Willebrand factor content, and circulating plasminogen activator inhibitor-1 are increased, but expression of endothelialleukocyte adhesion molecules is unchanged in insulin-dependent diabetic BBrats

      ATHEROSCLEROSIS
    71. Simon, D; Bandinelli, E; Roisenberg, I
      Von Willebrand factor gene polymorphisms in three Brazilian ethnic groups

      HUMAN BIOLOGY
    72. Vigo, AP; de Pedro, CZ; Jodra, MH
      Diagnostic criteria and differential diagnosis of thrombotic thrombocytopenic purpura

      REVISTA CLINICA ESPANOLA
    73. Homoncik, M; Blann, AD; Hollenstein, U; Pernerstorfer, T; Eichler, HG; Jilma, B
      Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100

      BRITISH JOURNAL OF HAEMATOLOGY
    74. Song, S; Freedman, J; Mody, M; Lazarus, AH
      Porcine von Willebrand factor and thrombin induce the activation of c-Jun amino-terminal kinase (JNK/SAPK) whereas only thrombin induces activation of extracellular signal-related kinase 2 (ERK2) in human platelets

      BRITISH JOURNAL OF HAEMATOLOGY
    75. Schwaab, R; Oldenburg, J; Kemball-Cook, G; Albert, T; Juhler, C; Hanfland, P; Ingerslev, J
      Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family

      BRITISH JOURNAL OF HAEMATOLOGY
    76. Kondo, H; Imamura, T
      Effects of intravenous immunoglobulin in a patient with intermittent thrombotic thrombocytopenic purpura

      BRITISH JOURNAL OF HAEMATOLOGY
    77. Haberichter, SL; Fahs, SA; Montgomery, RR
      Von Willebrand factor storage and multimerization: 2 independent intracellular processes

      BLOOD
    78. Allen, S; Abuzenadah, AM; Hinks, J; Blagg, JL; Gursel, T; Ingerslev, J; Goodeve, AC; Peake, IR; Daly, ME
      A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion

      BLOOD
    79. Allen, S; Abuzenadah, AM; Blagg, JL; Hinks, J; Nesbitt, IM; Goodeve, AC; Gursel, T; Ingerslev, J; Peake, IR; Daly, ME
      Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor

      BLOOD
    80. Ajzenberg, N; Ribba, AS; Rastegar-Lari, G; Meyer, D; Baruch, D
      Effect of recombinant von Willebrand factor reproducing type 2B or type 2Mmutations on shear-induced platelet aggregation

      BLOOD
    81. Jorieux, S; Fressinaud, E; Goudemand, J; Gaucher, C; Meyer, D; Mazurier, C
      Conformational changes in the D ' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment

      BLOOD
    82. Favaloro, EJ
      Detection of von Willebrand disorder and identification of qualitative vonWillebrand factor defects - Direct comparison of commercial ELISA-based von Willebrand factor activity options

      AJCP. American journal of clinical pathology
    83. Thomas, KB; Urbancik, W; Turecek, PL; Gritsch, H; Schreiber, J; Weber, A; Schonhofer, W; Strauss, M; Linnau, Y; Schoppmann, A
      Continuous infusion of FVIII and FIX concentrates: in vitro analysis of clinically relevant parameters

      HAEMOPHILIA
    84. Berntorp, E; Ingerslev, J; Schulman, S
      von Willebrand disease: an update in the Aland islands

      HAEMOPHILIA
    85. Blomback, M
      Scientific visits to the Aland islands

      HAEMOPHILIA
    86. Ingerslev, J; Gursel, T
      Diagnosis of von Willebrand disease

      HAEMOPHILIA
    87. Kekomaki, R; Rasi, V; Ebeling, F; Vahtera, E; Javela, K; Koski, T; Myllyla, G; Ikkala, E
      von Willebrand disease in Finland

      HAEMOPHILIA
    88. Mohlke, KL; Nichols, WC; Ginsburg, D
      The molecular basis of von Willebrand disease

      INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
    89. Fischer, BE
      Recombinant von Willebrand factor: Potential therapeutic use

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    90. Huchon, D; Catzeflis, FM; Douzery, EJP
      Molecular evolution of the nuclear von Willebrand Factor gene in mammals and the phylogeny of rodents

      MOLECULAR BIOLOGY AND EVOLUTION
    91. Menegatti, M; Cristalli, G; Gallo, L; Mannucci, PM; Pareti, FI
      Effect of adenosine derivatives on in vitro thrombus formation induced by shear stress

      HAEMATOLOGICA
    92. Corte-Real, F; Souto, L; Anjos, MJ; Carvalho, M; Vieira, DN; Carracedo, A; Vide, MC
      Population distribution of six PCR-amplified loci in Madeira Archipelago (Portugal)

      FORENSIC SCIENCE INTERNATIONAL
    93. Obert, B; Tout, H; Veyradier, A; Fressinaud, E; Meyer, D; Girma, JP
      Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF

      THROMBOSIS AND HAEMOSTASIS
    94. Keeney, S; Cumming, A; Hay, C
      Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease

      THROMBOSIS AND HAEMOSTASIS
    95. Nesbitt, IM; Hampton, KK; Preston, FE; Peake, IR; Goodeve, AC
      A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations

      THROMBOSIS AND HAEMOSTASIS
    96. Verkleij, MW; IJsseldijk, MJW; Heijnen-Snyder, GJ; Huizinga, EG; Morton, LF; Knight, CG; Sixma, JJ; de Groot, PG; Barnes, MJ
      Adhesive domains in the collagen III fragment alpha 1(III)CB4 that supportalpha 2 beta 1-and von Willebrand factor-mediated platelet adhesion under flow conditions

      THROMBOSIS AND HAEMOSTASIS
    97. Ruggeri, ZM
      Structure and function of von Willebrand factor

      THROMBOSIS AND HAEMOSTASIS
    98. Furian, M; Lammle, B
      Von Willebrand factor in thrombotic thrombocytopenic purpura

      THROMBOSIS AND HAEMOSTASIS
    99. Furlan, M; Robles, R; Morselli, B; Sandoz, P; Lammle, B
      Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura

      THROMBOSIS AND HAEMOSTASIS
    100. Favaloro, EJ
      Laboratory assessment as a critical component of the appropriate diagnosisand sub-classification of von Willebrand's disease

      BLOOD REVIEWS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 03:11:12